Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
10.3Enterprise Value over EBITDA
VS
Market
Sector
Industry
History
$ 1.86Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information
Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTPROTALIX BIOTHERAPEUTICS INC - Enterprise Value over EBITDA Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PLX - EV/EBITDA Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Enterprise Value | Enterprise Value over EBITDA |
|---|---|---|---|
| 6/30/2025 | $ 10.55M | $ 108.65M | 10.3 |
| 3/31/2025 | $ 7.16M | $ 122.7M | 17.13 |
| 12/31/2024 | $ 6.52M | $ 176.95M | 27.14 |
| 9/30/2024 | $ -7.76M | $ 82.1M | 0 |
| 6/30/2024 | $ -13.19M | $ 71.15M | 0 |
| 3/31/2024 | $ 9.64M | $ 79.81M | 8.27 |
| 12/31/2023 | $ 11.65M | $ 102.73M | 8.82 |
| 9/30/2023 | $ 15.89M | $ 115.76M | 7.28 |
| 6/30/2023 | $ 13.99M | $ 113.79M | 8.13 |
| 3/31/2023 | $ -11.69M | $ 220.33M | 0 |
Key Performance Insights, Last 5 Years
- PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) EV/EBITDA stands at 46.28.
- Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average EV/EBITDA has been 21.76.
- The median EV/EBITDA for PROTALIX BIOTHERAPEUTICS INC during this period was 10.3
- PROTALIX BIOTHERAPEUTICS INC reached its highest EV/EBITDA over the past 5 years at 62.52.
- The lowest EV/EBITDA recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe 7.28
PROTALIX BIOTHERAPEUTICS INC's EV/EBITDA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/EBITDA Benchmarks
Similar metrics to EV/EBITDA:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) - [Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
Definition of Enterprise Value over EBITDA
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].EV / EBITDA
(=) EV/EBITDA EV/EBITDA for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: EV [ $ 161.68M ] / EBITDA [ $ 3.49M ]
(=) EV/EBITDA [ 46.28 ] PLX - Enterprise Value over EBITDA, Last 5 years
7.28
Minimum
Sep 30, 2023
62.52
Maximum
Dec 31, 2020
21.76
Average
10.3
Median
EV/EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.48 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
| filtered constituents | 2.44K |
|---|---|
| min | 0.01 |
| max | 40.82 |
| average | 13.48 |
| median | 11.75 |
| std | 7.65 |